Reducing the Costs of Medical Device Clinical Trials: Is This an Overlooked Aspect of Healthcare Reform?
Interview with Molly Blake-Michaels
In a world where healthcare budgets are being constantly squeezed, it’s incredibly important to ensure that one of the most fundamental steps in medical device development – the clinical trial – is planned as effectively and efficiently as possible. Therefore, we enlisted the help of Molly Blake-Michaels to enlighten us on the challenges unique to designing medical device clinical trials. In this interview, Molly shares her expertise regarding the planning, forecasting, and tracking of medical device clinical trials and the concepts that can be employed to help overcome the associated hurdles.
Okay, so who is Molly Blake-Michaels? She is Senior Director of Clinical Services for ClearTrial. And what exactly is ClearTrial? ClearTrial provides Clinical Trial Operations (CTO) software that makes the planning, forecasting, and tracking of clinical project and financial performance faster and more accurate. Before joining ClearTrial, Molly spent over 20 years in clinical trial operations with companies like Abbott, Fujisawa, Hospira, and Delta Pharma.
You May Like These Articles
Medsider Premium
Become a premium member and unlock access to exclusive Medsider benefits.